Pausing post-COVID fatigue

Phase 2

• Conditions: Post-COVID fatigue; Infections and Infestations

• Registration Number: ISRCTN18015802
• Lead Sponsor: ewcastle University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-12
• Last Update Posted: 25 March 2024
• Study Completion: 2025-03-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

1. Members of the public (adults) who have a verifiable positive COVID diagnosis (COVID+) but who did not require hospitalisation and who are at least 4 weeks after diagnosis, will be recruited via the trial website (http://covidfatigue.org.uk/), social media and radio advertisements. They will be screened for symptoms of fatigue using an electronic implementation of the Fatigue Impact Scale
2. Aged =18 and <65 years
3. Able to provide written informed consent in English
4. No previous diagnosis of neurological or psychiatric disorder
5. No cardiac disease (e.g., cardiomyopathy, myocardial infarction, arrhythmia, prolonged QT interval, etc)
6. No implanted device (e.g., pacemaker)
7. Not pregnant
8. Fluent in English

Exclusion Criteria

1. Previous diagnosis of neurological or psychiatric disorder
2. Cardiac disease (e.g., cardiomyopathy, myocardial infarction, arrhythmia, prolonged QT interval, etc)
3. Implanted device (e.g., pacemaker)
4. Pregnant
5. Not fluent in English

Study & Design

• Study Type: Interventional
• Study Design: Not specified